Screener
Harmony Biosciences Holdings, Inc. HRMY Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $261.28M+30.3% | $215.39M+16.6% | $243.78M+21.1% | $239.46M+28.7% | $200.49M+16.0% | ||
| $63.2M+65.6% | $44.51M+39.1% | $68.55M+26.0% | $59.65M+39.4% | $38.15M+18.7% | ||
| $198.08M+22.0% | $170.88M+11.9% | $175.23M+19.3% | $179.81M+25.5% | $162.34M+15.4% | ||
| 75.8%-5.2pp | 79.3%-3.3pp | 71.9%-1.1pp | 75.1%-1.9pp | 81%-0.4pp | ||
| $46.6M-7.1% | $69.38M+101% | $49.93M+44.0% | $54.96M+116% | $50.16M-21.1% | ||
| $34.12M+13.5% | $31.69M+3.2% | $29.18M+5.7% | $29.55M+7.2% | $30.07M+5.5% | ||
| $28.05M-17.3% | $32.51M+4.0% | $57.56M+99.4% | $29.81M+4.3% | $33.92M+24.6% | ||
| $108.77M-4.7% | $133.58M+38.4% | $136.67M+50.0% | $114.32M+40.2% | $114.16M-4.3% | ||
| $89.32M+85.4% | $37.29M-33.7% | $38.56M-30.8% | $65.49M+6.1% | $48.18M+126% | ||
| 34.2%+10.2pp | 17.3%-13.1pp | 15.8%-11.9pp | 27.3%-5.8pp | 24%+11.7pp | ||
| $3.07M-15.8% | $3.23M-15.7% | $3.55M-15.8% | $3.62M-16.7% | $3.65M-17.2% | ||
| -$53K+72.5% | -$127K+54.0% | -$105K— | -$106K+14.5% | -$193K-622% | ||
| $93.27M+87.9% | $39.69M-30.6% | $40.76M-27.4% | $67.49M+8.6% | $49.64M+129% | ||
| $17.83M+80.9% | $7.2M-38.0% | $18.27M+174% | $16.63M+3.4% | $9.86M-2.4% | ||
| $75.43M+89.6% | $32.49M-28.7% | $22.49M-54.6% | $50.87M+10.4% | $39.78M+243% | ||
| 28.9%+9.0pp | 15.1%-9.6pp | 9.2%-15.4pp | 21.2%-3.5pp | 19.8%+13.1pp | ||
| $1.28+88.2% | $0.55-29.5% | $0.39-54.1% | $0.87+10.1% | $0.68+240% | ||
| $95.28M+76.0% | $43.26M-30.5% | $44.52M-27.8% | $71.46M+5.6% | $54.15M+97.6% | ||
| 36.5%+9.5pp | 20.1%-13.6pp | 18.3%-12.4pp | 29.8%-6.5pp | 27%+11.1pp | ||
| $89.32M+85.4% | $37.29M-33.7% | $38.56M-30.8% | $65.49M+6.1% | $48.18M+126% |
FAQ
- What is Harmony Biosciences Holdings, Inc.'s revenue?
- Harmony Biosciences Holdings, Inc. (HRMY) generated $959.9M in revenue over the trailing twelve months, up 24.3% year over year.
- Is Harmony Biosciences Holdings, Inc. profitable?
- Harmony Biosciences Holdings, Inc. reported $181.3M in net income over the trailing twelve months, a 18.9% net margin.
- What are Harmony Biosciences Holdings, Inc.'s profit margins?
- Gross margin is 75.4% and operating margin is 24.0%, with a 18.9% net margin.
- What is Harmony Biosciences Holdings, Inc.'s earnings per share?
- Harmony Biosciences Holdings, Inc.'s diluted EPS over the trailing twelve months is $3.09.
- Where does Harmony Biosciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
